Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Discovery: Overview01:26

Drug Discovery: Overview

Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
Drug Administration and Therapy Phases: Overview01:26

Drug Administration and Therapy Phases: Overview

Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
Clinically Relevant Drug Product Specifications: Methods of Establishment01:29

Clinically Relevant Drug Product Specifications: Methods of Establishment

Product specifications define the acceptable quality of a pharmaceutical product by ensuring identity, purity, potency, and strength. These specifications serve as benchmarks during development, manufacturing, and post-approval quality control. Clinically relevant specifications are particularly important because they directly relate to a drug's safety and efficacy in clinical use.Dissolution studies are critical biopharmaceutic tools that link in vitro behavior to in vivo performance. They...
Drug Nomenclature01:17

Drug Nomenclature

During the development of a new pharmaceutical, the manufacturer initially assigns a code name to the drug. Once approved, the drug receives a United States Adopted Name (USAN)—a generic, nonproprietary designation. Upon being listed in the United States Pharmacopeia, this nonproprietary name becomes the drug's official name. Additionally, the manufacturer assigns a proprietary name or trademark, which serves as the brand name under which the drug is marketed. It is worth noting that the same...
Drug Classes and Categories01:25

Drug Classes and Categories

Drugs can be classified according to their chemical composition or their intended therapeutic application. For instance, anti-infective agents that possess the ability to eliminate pathogens or suppress their growth and reproduction can be grouped based on the organisms they target or their chemical structure. Furthermore, drugs can be divided into prescription, nonprescription, or controlled substances. Prescription medications, such as antibiotics, require oversight from a licensed healthcare...
Biopharmaceutics and Pharmacokinetics: Overview01:28

Biopharmaceutics and Pharmacokinetics: Overview

Understanding drugs, drug products, and their performance in pharmaceutical science is pivotal. Drugs, whether simple molecules or complex compounds, are designed to interact with the body's biological systems to diagnose, treat, or prevent diseases. Drug products include various delivery systems such as tablets, capsules, injections, and inhalers. The performance of these drug products is gauged by their ability to deliver the active ingredient to the desired site of action at the appropriate...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Accommodating Pharmacy Students With Physical Disabilities During the Experiential Learning Curricula.

American journal of pharmaceutical education·2022
Same author

Fostering Interprofessional Education Through a Multidisciplinary, Community-Based Pandemic Mass Vaccination Exercise.

American journal of public health·2018
See all related articles

Related Experiment Videos

Identifying Foundational Drug Knowledge in Pharmacy Education Using a Structured Consensus Framework.

Benjamin Shultz1, Kathryn Sawyer1, Allison Schriever1

  • 1University of Illinois Chicago Retzky College of Pharmacy, Chicago, Illinois, USA.

Journal of the American College of Clinical Pharmacy : JACCP
|July 9, 2026
PubMed
Summary
This summary is machine-generated.

A consensus study identified 218 essential drugs for pharmacy education, creating a validated foundational drug list. This framework guides curriculum development and assessment for practice-readiness.

Keywords:
clinical competencecurriculumdrug knowledgepharmacy education

Related Experiment Videos

Area of Science:

  • Pharmacy Education
  • Pharmacotherapeutics
  • Curriculum Development

Background:

  • Pharmacy programs lack standardized guidance on essential drug prioritization for practice-readiness.
  • Existing volume-derived drug lists may not encompass the full spectrum of medications used in diverse practice settings.

Purpose of the Study:

  • To establish a consensus-based foundational drug list that accurately reflects the breadth of pharmacy practice.
  • To provide a validated resource for prioritizing medications in pharmacy curricula.

Main Methods:

  • A multi-phase consensus study using the Lawshe method to determine content validity of essential drugs.
  • Expert panels of academics and practicing pharmacists evaluated an initial inventory of 1381 drugs.
  • Statistical analysis and the Jaccard Similarity index were used to refine the list and compare it with commercial drug lists.

Main Results:

  • A total of 218 drugs achieved consensus, with 78 reaching unanimous agreement.
  • Cardiovascular, central nervous system, and anti-infective classes were highly represented.
  • The consensus list showed limited overlap (Jaccard index 0.408) with a commercial Top 300 Drugs list, highlighting gaps in critical care and anti-infective medications.

Conclusions:

  • A validated, consensus-derived framework of 218 foundational drugs offers a replicable methodology for pharmacy programs.
  • The framework supports focused, longitudinal assessment rather than solely altering taught content.
  • This approach enhances pharmacy students' practice-readiness through targeted drug knowledge development.